{
    "nctId": "NCT02686918",
    "briefTitle": "Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse",
    "officialTitle": "Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse - TIPA",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Percentage of consultation requiring a medical advice between IPA and oncologist",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient care at the Cancer Institute Lucien Neuwirth\n* Patient aged over 18 years\n* Patient with breast cancer overexpressing HER2 adjuvant\n* Patient having finished their chemotherapy treatment with IV followed the oncologist day hospital\n* Patient under Trastzumab subcutaneously\n* Patient affiliated or entitled to a social security scheme (mandatory requirement for all studies)\n\nExclusion Criteria:\n\n* Refusal to participate, most patient protected under guardianship.\n* Patient in inability to understand the course of the study\n* Patient with documented history of cognitive or psychiatric disorders.\n* Patients pregnant or lactating\n* Patients under guardianship or curatorship",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}